Paper455885
Plasma clearance of propranolol and sotalol and hepatic drug-metabolizing enzyme activity.
Sotaniemi EA and 4 others. Clin Pharmacol Ther, 1979. Cited by 51 papers, by iCite.
Cite this record
ConductScience Library. Plasma clearance of propranolol and sotalol and hepatic drug-metabolizing enzyme activity. Papers, record 455885. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/455885
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Plasma clearance of propranolol and sotalol and hepatic drug-metabolizing enzyme activity.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Liver | Major topic |
| Propranolol | Major topic |
| Sotalol | Major topic |
| Adult | |
| Aged | |
| Angina Pectoris | |
| Antipyrine | |
| Cytochrome P-450 Enzyme System | |
| Female | |
| Half-Life | |
| Humans | |
| Hypertension | |
| Male | |
| Middle Aged |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 24271521 | Correlation between in vivo antipyrine metabolite formation and theophylline metabolism in rats. | Pharm Res | 1986 | https://conductscience.org/library/papers/24271521 | PubMed |
| 12844326 | Therapeutic drug monitoring of antiarrhythmic drugs. | Clin Pharmacokinet | 2003 | https://conductscience.org/library/papers/12844326 | PubMed |
| 7506652 | Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias. | Drugs | 1993 | https://conductscience.org/library/papers/7506652 | PubMed |
| 7308271 | Influence of liver disease and environmental factors on hepatic monooxygenase activity in vitro. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7308271 | PubMed |
| 7106158 | Elimination of pindolol in liver disease. | Eur J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7106158 | PubMed |
| 7014827 | A standard approach to compiling clinical pharmacokinetic data. | J Pharmacokinet Biopharm | 1981 | https://conductscience.org/library/papers/7014827 | PubMed |
| 6714293 | The effect of liver cirrhosis on the pharmacokinetics of phenprocoumon. | Eur J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6714293 | PubMed |
| 6639842 | Induction of propranolol metabolism by rifampicin. | Br J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6639842 | PubMed |
| 6342901 | Pharmacokinetic drug interactions with propranolol. | Clin Pharmacokinet | 1983 | https://conductscience.org/library/papers/6342901 | PubMed |
| 6146342 | Enzyme induction and beta-adrenergic receptor blocking drugs. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6146342 | PubMed |
| 6146338 | Prediction of metabolic drug interactions involving beta-adrenoceptor blocking drugs. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6146338 | PubMed |
| 6105079 | Measurement of hepatic drug-metabolizing enxyme activity in man. Comparison of three different assays. | Eur J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/6105079 | PubMed |
| 3987778 | Relationship between lipid composition and drug metabolizing capacity of human liver. | Eur J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/3987778 | PubMed |
| 3770017 | Liver drug metabolism and blood pressure response to a lipophilic and hydrophilic beta blocker. | Eur J Drug Metab Pharmacokinet | 1986 | https://conductscience.org/library/papers/3770017 | PubMed |
| 3315621 | Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use. | Drugs | 1987 | https://conductscience.org/library/papers/3315621 | PubMed |
| 2865154 | Polymorphic metabolism of the beta-adrenoreceptor blocking drugs and its clinical relevance. | Eur J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/2865154 | PubMed |
| 2864639 | Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat. | Naunyn Schmiedebergs Arch Pharmacol | 1985 | https://conductscience.org/library/papers/2864639 | PubMed |
| 2612519 | The effect of a single treatment with cigarette smoke on the blood levels and hemodynamic effects of propranolol in rats. | Eur J Drug Metab Pharmacokinet | 1989 | https://conductscience.org/library/papers/2612519 | PubMed |
| 2373132 | The pharmacokinetics of d-sotalol and d,l-sotalol in healthy volunteers. | Eur J Clin Pharmacol | 1990 | https://conductscience.org/library/papers/2373132 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CYP4F3 | 4051 | PubTator's text mining | https://conductscience.org/library/genes/4051 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/455885
GET https://conductscience.org/api/papers/v1/455885/authors